Indonesia's Kimia Farma, Malaysian Company Collaborate in Laboratory Services

JAKARTA, KOMPAS.com - State-owned pharmaceutical firm PT Kimia Farma forged cooperation with a medical laboratory services provider from Malaysia to foster the development of diagnostic laboratory services.

The cooperation agreed on the provision of assistance and technical knowledge support for the development of diagnostic laboratory services. Thus, through the implementation of the collaboration, Kimia Farma can enhance the quality and services of its laboratories.

President Director of PT Kimia Farma David Utama said on Wednesday, Oct. 19, that his firm continues to make efforts to provide easier access to health services to the community through its pharmacy, health clinic, and diagnostic laboratory networks spread across Indonesia.

"Currently, Kimia Farma has 72 diagnostic laboratories. Kimia Farma took a step to improve laboratory services to [match] international standards through cooperation with Pantai Premier Pathology Sdn. Bhd.," he said.

Also read: Acute Hepatitis Not Linked to Covid-19 Vaccination, Says Indonesia’s Health Ministry

The cooperation between Kimia Farma and Pantai Premier Pathology covers human resource development programs through training and competency improvement, supported by the transfer of knowledge and technology between the two parties.

By exchanging knowledge and technology, Kimia Farma is optimistic about increasing and expanding the range of expertise in the aspect of human resources and service quality.

Pantai Premier Pathology Chief Executive Officer Mohd Hareeff Muhammed said his side is honored to be working with Kimia Farma to conduct healthcare transformation and health improvement for Indonesians.

Also read: Indonesia’s Digital Health Program Gets Support from Bill Gates

"As one of the providers of comprehensive diagnostic services in Malaysia and part of the IHH Laboratory, we [Pantai Premier Pathology] hope to share knowledge and expertise with Kimia Farma and improve diagnostic services in Indonesia," he said.

Through the signing of a memorandum of understanding, Kimia Farma and Pantai Premier Pathology targeted to record an increase in service excellence, human resource skills, and leading technology, so that Kimia Farma can become the best provider in Indonesia.

Source: State News Antara